Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat

Table 3 Effect of lycopene on low density lipoprotein-cholesterol, high density lipoprotein-cholesterol and free fatty acid levels in liver tissue

Group	LDL-C (mmol/L)	HDL-C (mmol/L)	FFA (mmol/L)
Control	0.34 ± 0.08	0.98 ± 0.10	0.82 ± 0.13
Model	2.48 ± 0.13b	0.55 ± 0.02b	2.03 ± 0.15b
Ly 5 mg/kg	1.32 ± 0.10c	0.70 ± 0.04c	1.73 ± 0.12
Ly 10 mg/kg	0.95 ± 0.05d	0.80 ± 0.05d	1.56 ± 0.10c
Ly 20 mg/kg	0.62 ± 0.08d	0.87 ± 0.05d	1.34 ± 0.08d

Data are expressed as mean ± SD (n = 12) for each group.

^bP < 0.01 vs control group;

^cP < 0.05,

^dP < 0.01 vs model group. Ly: Lycopene; LDL-C: Low density lipoprotein-cholesterol; HDL-C: High density lipoprotein-cholesterol; FFA: Free fatty acid.